| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,625 |
2,199 |
$246K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,359 |
2,840 |
$216K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,862 |
9,306 |
$210K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,685 |
1,310 |
$152K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
2,757 |
2,311 |
$144K |
| 93880 |
|
2,592 |
2,168 |
$109K |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,695 |
1,432 |
$82K |
| 93000 |
|
14,251 |
11,812 |
$77K |
| 93224 |
|
1,763 |
1,657 |
$71K |
| 93015 |
|
2,883 |
2,414 |
$69K |
| 99215 |
Prolong outpt/office vis |
3,421 |
2,800 |
$64K |
| 93923 |
|
1,249 |
1,104 |
$41K |
| 93970 |
|
639 |
557 |
$30K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,685 |
2,979 |
$16K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
702 |
540 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,990 |
1,105 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
124 |
102 |
$6K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
402 |
358 |
$5K |
| 90686 |
|
990 |
842 |
$4K |
| 94010 |
|
539 |
479 |
$4K |
| 93244 |
|
452 |
377 |
$3K |
| 93242 |
|
453 |
378 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
709 |
602 |
$1K |
| 90677 |
|
34 |
28 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
1,474 |
1,264 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
253 |
199 |
$1K |
| 1158F |
|
1,143 |
1,021 |
$950.00 |
| 1157F |
|
1,143 |
1,021 |
$950.00 |
| 1159F |
|
1,140 |
1,018 |
$900.00 |
| 1160F |
|
1,142 |
1,021 |
$880.00 |
| 3008F |
|
1,078 |
965 |
$830.00 |
| 99406 |
|
296 |
253 |
$717.29 |
| 75635 |
|
66 |
57 |
$626.38 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
784 |
676 |
$505.37 |
| J3490 |
Unclassified drugs |
275 |
214 |
$381.56 |
| 70498 |
|
24 |
24 |
$252.08 |
| 70496 |
|
26 |
25 |
$241.57 |
| 3077F |
|
69 |
59 |
$70.00 |
| 3074F |
|
80 |
72 |
$60.00 |
| 3078F |
|
128 |
116 |
$50.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
12 |
12 |
$46.74 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
111 |
92 |
$45.69 |
| G0008 |
Administration of influenza virus vaccine |
630 |
569 |
$39.69 |
| 3080F |
|
17 |
12 |
$30.00 |
| 82962 |
|
15 |
13 |
$24.12 |
| 80305 |
|
26 |
15 |
$23.60 |
| 3079F |
|
12 |
12 |
$20.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
398 |
382 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
44 |
42 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
243 |
232 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
13 |
12 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
78 |
73 |
$0.00 |
| G1007 |
Clinical decision support mechanism aim specialty health, as defined by the medicare appropriate use criteria program |
93 |
85 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
108 |
102 |
$0.00 |
| 1123F |
|
398 |
382 |
$0.00 |